FDA NDC Directory · JSON-LD · Markdown
NDC 71904-200 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
| Generic name | cipaglucosidase alfa-atga |
|---|---|
| Labeler / Manufacturer | AMICUS THERAPEUTICS US, LLC |
| Marketing category | Biologic License Application · App BLA761204 |
| Dosage form / route | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS |
| Active ingredients | CIPAGLUCOSIDASE ALFA (105 mg/1) |
| Marketing started | 20231011 |
| Package count | 3 |
Source: openFDA. Public-domain (CC0).